Related Experiment Video
Updated: Aug 7, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
A Novel Loss-of-function Mutation in MYBPC3 Causes Familial Hypertrophic Cardiomyopathy with Extreme Intrafamilial
Y Peng1,2,3, J Xu1,2,3, Y Wang1,2,3
1Department of Cardiology, the First Hospital of Lanzhou University, Lanzhou, China.
Insights
A novel deletion in the MYBPC3 gene was identified in a Chinese patient with hypertrophic cardiomyopathy (HCM). This finding underscores the importance of whole exome sequencing for diagnosing familial HCM.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- Cardiomyopathies, particularly hypertrophic cardiomyopathy (HCM), are heart muscle diseases often caused by genetic mutations.
- MYBPC3 gene mutations are a common cause of HCM, but exhibit significant variability in disease presentation.
- Understanding genetic underpinnings is crucial for diagnosing and managing HCM.
Purpose of the Study:
- To investigate the genetic cause of hypertrophic cardiomyopathy in a Chinese patient.
- To identify novel mutations in the MYBPC3 gene associated with HCM.
- To evaluate the utility of whole exome sequencing in diagnosing familial HCM.
Main Methods:
- Whole exome sequencing was performed on a patient diagnosed with HCM.
- Genetic variant analysis was conducted to identify mutations in the MYBPC3 gene.
- Segregation analysis was performed within the patient's family.
Main Results:
- A novel heterozygous deletion (c.3781_3785delGAGGC) in exon 33 of the MYBPC3 gene was identified in the proband.
- This deletion results in a frameshift mutation (p.Glu1261Thrfs*3), predicted to produce a truncated MYBPC3 protein.
- The variant was found in the proband's father but not in the mother, consistent with familial inheritance.
Conclusions:
- A novel MYBPC3 gene deletion is associated with hypertrophic cardiomyopathy in this Chinese family.
- Whole exome sequencing is a valuable tool for the molecular diagnosis of familial HCM.
- Further research is needed to understand the phenotypic heterogeneity associated with MYBPC3 mutations.
Abstract:
Cardiomyopathies are a heterogeneous group of diseases predominantly affecting the heart muscle and often lead to progressive heart failure-related disability or cardiovascular death. Hypertrophic cardiomyopathy (HCM) is a cardiac muscle disorder mostly caused by the mutations in genes encoding cardiac sarcomere. Germ-line mutations in MYBPC3 causes hypertrophic cardiomyopathy (HCM). However, most of the HCM associated MYBPC3 mutations were truncating mutations. Extreme phenotypic heterogeneity was observed among HCM patients with MYBPC3 mutations. In this study, we investigated a Chinese man who presented with HCM. Whole exome sequencing identified a novel heterozygous deletion (c.3781_3785delGAGGC) in exon 33 of the MYBPC3 in the proband. This heterozygous variant causes frameshift (p.Glu1261Thrfs*3), which predicted to form a truncated MYBPC3 protein. The proband's father also carries this variant in a heterozygous state while the proband's mother did not harbor this variant. Here, we report on a novel deletion in the MYBPC3 gene associated with HCM. We also highlight the importance of whole exome sequencing for molecular diagnosis for the patients with familial HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

